GEOVAX LABS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
GEOVAX LABS, INC. (GOVX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $123.91 thousand as of 2026-06-30, per its S-1 filed 2026-09-17.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-09-17
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $123.91K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $123.91K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $313.88K.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $171.21K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $123.91K S-1 · filed 2026-09-17 |
| 2026-03-31 | $123.91K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $313.88K S-1 · filed 2026-09-17 |
| 2020-12-31 | $171.21K 10-K · filed 2021-03-23 |
| 2020-09-30 | $171.21K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $171.21K 10-Q · filed 2020-08-10 |
| 2019-12-31 | $166.16K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |